Fig. 4From: EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancersMechanisms of EZH2 inhibitor synthetic lethality in ARID1A mutated tumors. Balanced action of EZH2 and ARID1A are necessary for normal cellular functionBack to article page